Recent

% | $
Quotes you view appear here for quick access.

Pernix Therapeutics Holdings, Inc. Message Board

amosshy 1 post  |  Last Activity: Mar 28, 2015 10:38 PM Member since: Oct 14, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • On Nov. 12, 2014, 10-Q “We expect to report positive data from our U.S. Phase 3 study of KamRAB, a human rabies immune globulin for the post-exposure prophylactic treatment of rabies, by the end of the year and to file a Biologics License Application with the FDA in the first half of 2015."
    On Feb.11, 2015 10-K “In addition, we expect to report data from our anti-rabies immunoglobulin U.S. Phase 2/3 clinical trial for the post-exposure prophylactic treatment of rabies by mid-year, and subject to positive data, to file a Biologics License Application (BLA) with the FDA in the second half of 2015."

    Is this a cheating?

PTX
6.38-0.280(-4.20%)May 5 4:00 PMEDT